Morgan Stanley Exagen Inc. Put Options Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding XGN
# of Institutions
41Shares Held
5.94MCall Options Held
4.5KPut Options Held
400-
Rtw Investments, LP New York, NY1.51MShares$6.35 Million0.1% of portfolio
-
Cowen And Company, LLC891KShares$3.74 Million0.07% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY535KShares$2.25 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$2.06 Million0.0% of portfolio
-
Perkins Capital Management Inc424KShares$1.78 Million1.67% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $68.3M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...